Academic Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2020

  1. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

    Modern Pathology, Vol. 33, Núm. 5, pp. 792-801

2015

  1. Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use

    International Journal of Cancer, Vol. 137, Núm. 4, pp. 868-877

2013

  1. snoRNPs regulate telomerase activity in neuroblastoma and are associated with poor prognosis

    Translational Oncology, Vol. 6, Núm. 4, pp. 447-457

2012

  1. Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

    British Journal of Cancer, Vol. 107, Núm. 8, pp. 1409-1417

2011

  1. Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas

    Genes Chromosomes and Cancer, Vol. 50, Núm. 4, pp. 250-262

  2. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

    Clinical Cancer Research, Vol. 17, Núm. 24, pp. 7684-7692